In 2023, the share of corresponding/leading authors in scientific publications in endocrinology in the US was just slightly above 92.35%, demonstrating a consistent decline projected from 2024 through 2028. The forecasted data indicates a marginal year-on-year decline, showing gradual stabilization in the market with the share of corresponding authors decreasing by approximately 0.19% annually. The compound annual growth rate (CAGR) further underscores this consistently negligible dip over the five years.

Future trends to watch for:

An increasing focus on collaborative research efforts might impact the share of corresponding authors.
Technological advancements could influence publishing dynamics.
Policy changes regarding author contributions could further shift trends.